Rationale and design of the CANARI study: a case–control study investigating the association between prostate cancer and 5‐alpha‐reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France

Publisher： John Wiley & Sons Inc

E-ISSN： 1472-8206|32|1|120-129

ISSN： 0767-3981

Source： Fundamental & Clinical Pharmacology, Vol.32, Iss.1, 2018-02, pp. : 120-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations

By Earnshaw Stephanie R.  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 489-505

Adis International

Access to resources Recommend Favorite

Interleukin-1 Receptor Antagonist Polymorphism in Patients with Prostate Cancer and Benign Prostatic Hyperplasia: A Case Control Study from North India

By Mittal R.D.   Mishra D.K.   Bid H.K.   Mandhani A.  

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 131-134

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Association Between Use of Acid-Suppressive Drugs and Risk of Gastric Cancer: A Nested Case-Control Study

By Tamim Hani  

Drug Safety, Vol. 31, Iss. 8, 2008-01 ,pp. : 675-684

Adis International

Access to resources Recommend Favorite

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer: A Nested Case-Control Study in UK Primary Care

By Martín-Merino Elisa  

Drug Safety, Vol. 34, Iss. 11, 2011-11 ,pp. : 1061-1077

Adis International

Access to resources Recommend Favorite

Family and case–control association study of the tumor necrosis factor-alpha (TNF-α) gene with schizophrenia and response to antipsychotic medication

By Zai Gwyneth   Müller Daniel   Volavka Jan   Czobor Pal   Lieberman Jeffrey   Meltzer Herbert   Kennedy James  

Psychopharmacology, Vol. 188, Iss. 2, 2006-10 ,pp. : 171-182

Springer Publishing Company

Access to resources Recommend Favorite